XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
AEMD Aethlon Medical
- 0.6156
- -0.0156-2.47%
Close Feb 14 16:00 ET
- 0.6298
- +0.0142+2.31%
Post 19:59 ET
8.90MMarket Cap-0.41P/E (TTM)
0.6448High0.6150Low382.87KVolume0.6250Open0.6312Pre Close237.26KTurnover2.67%Turnover RatioLossP/E (Static)14.46MShares1.850052wk High2.05P/B8.83MFloat Cap0.237552wk Low--Dividend TTM14.34MShs Float67499.9865Historical High--Div YieldTTM4.72%Amplitude0.2375Historical Low0.6190Avg Price1Lot Size
Aethlon Medical Stock Forum
Sign in to post a comment
$Aethlon Medical (AEMD.US)$
Aethlon's Hemopurifier Cancer Trial Milestone Achieved as Q3 Expenses Drop 50%
Aethlon's Hemopurifier Cancer Trial Milestone Achieved as Q3 Expenses Drop 50%
2
$Aethlon Medical (AEMD.US)$
Aethlon Medical Australian Treats First Patient in Hemopurifier® Cancer Trial
Aethlon Medical Australian Treats First Patient in Hemopurifier® Cancer Trial
1
$Aethlon Medical (AEMD.US)$
Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial
Wednesday, 29th January at 8:01 am
First Patient enrolled and treated at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital
Aethlon Advances Hemopurifier® Study in Solid Tumors Not Responding to Anti-PD-1 Antibodies
SAN DIEGO, Jan. 29, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic company focused on developing products to treat cancer and...
Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial
Wednesday, 29th January at 8:01 am
First Patient enrolled and treated at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital
Aethlon Advances Hemopurifier® Study in Solid Tumors Not Responding to Anti-PD-1 Antibodies
SAN DIEGO, Jan. 29, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic company focused on developing products to treat cancer and...
3
1
$Aethlon Medical (AEMD.US)$ Reuters
Just
Aethlon Medical : Aethlon Advances Hemopurifier® Study in Solid Tumors Not Responding to Anti-Pd-1 Antibodies
Just
Aethlon Medical : Aethlon Advances Hemopurifier® Study in Solid Tumors Not Responding to Anti-Pd-1 Antibodies
1
$Aethlon Medical (AEMD.US)$ $Tonix Pharmaceuticals (TNXP.US)$ $SIGA Technologies (SIGA.US)$ $Novavax (NVAX.US)$ $Pfizer (PFE.US)$ $iBio Inc (IBIO.US)$
This is silently worsening, and now we have an administration that is turning its back on science. It pulled away from the WHO. Trump's last term was damaging enough, but this time will be truly disastrous.
This is silently worsening, and now we have an administration that is turning its back on science. It pulled away from the WHO. Trump's last term was damaging enough, but this time will be truly disastrous.
3
NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you don’t appreciate my watchlist, STAY AW...
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you don’t appreciate my watchlist, STAY AW...
82
11
NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NE...
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NE...
109
35
16
No comment yet
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!
雷超 : What is it.